Page 10 - Vitamin D and Cancer
P. 10
Contributors
Tadayuki Akagi Ph.D.
Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA
School of Medicine, Los Angeles, CA, USA
Christine M. Barnett M.D.
Division of Hematology and Medical Oncology, Knight Cancer Institute,
Oregon Health & Science University, CH-14R, 3303 SW Bond Ave, Portland,
OR 97239, USA
Tomasz M. Beer M.D.
Division of Hematology & Medical Oncology, Oregon Health & Science
University, Knight Cancer Institute 3303 SN Bond Avenue, CH14R Portland,
OR 97239–3098, USA
Moray J. Campbell Ph.D.
Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute,
Elm & Carlton Streets, Buffalo, NY 14263, USA
Florence SG. Cheung M.D., Ph.D.
Plunkett Chair of Molecular Biology (Medicine), Bosch Institute, The University
of Sydney, Camperdown, NSW 2006, Australia
Heidi S. Cross Ph.D.
Department of Pathophysiology, Medical University of Vienna,
Waehringer Guertel 18–20, A-1090 Vienna, Austria
Marwan Fakih M.D.
Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA
David Feldman M.D.
Department of Medicine, Division of Endocrinology, Stanford University School
of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305–5103, USA
Barbara A. Foster Ph.D.
Pharmacology & Therapeutics, Roswell Park Cancer Institute, Elm & Carlton
Streets, Buffalo, NY 14263, USA
ix